Apeloa Pharmaceutical Co Ltd Cash Flow Quality Index
Apeloa Pharmaceutical Co Ltd cash flow quality index. Apeloa Pharmaceutical Co Ltd (000739) has a Cash Flow Quality Index of 2.34x as of December 2025. Operating cash flow of CN¥446.18 Million exceeds net income of CN¥190.41 Million, indicating high earnings quality where cash backs reported profits. See 000739 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Apeloa Pharmaceutical Co Ltd (1998–2025)
Cash flow quality index of Apeloa Pharmaceutical Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Apeloa Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 000739 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Apeloa Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1998–2025)
Apeloa Pharmaceutical Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Apeloa Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 000739 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.38x | CN¥1.23 Billion | CN¥890.68 Million | ▲ +17.8% |
| 2024 | 1.17x | CN¥1.21 Billion | CN¥1.03 Billion | ▲ +20.0% |
| 2023 | 0.98x | CN¥1.03 Billion | CN¥1.06 Billion | ▼ -27.1% |
| 2022 | 1.34x | CN¥1.33 Billion | CN¥989.17 Million | ▲ +109.4% |
| 2021 | 0.64x | CN¥611.75 Million | CN¥955.55 Million | ▼ -50.7% |
| 2020 | 1.30x | CN¥1.06 Billion | CN¥816.73 Million | ▼ -47.2% |
| 2019 | 2.46x | CN¥1.36 Billion | CN¥553.40 Million | ▲ +9.4% |
| 2018 | 2.25x | CN¥832.69 Million | CN¥370.57 Million | ▲ +174.8% |
| 2017 | 0.82x | CN¥209.80 Million | CN¥256.59 Million | ▲ +19.1% |
| 2016 | 0.69x | CN¥180.42 Million | CN¥262.90 Million | ▼ -67.6% |
| 2015 | 2.12x | CN¥441.16 Million | CN¥208.23 Million | ▼ -12.0% |
| 2014 | 2.41x | CN¥786.64 Million | CN¥326.72 Million | ▲ +103.5% |
| 2013 | 1.18x | CN¥190.45 Million | CN¥160.99 Million | ▼ -52.6% |
| 2012 | 2.50x | CN¥335.90 Million | CN¥134.55 Million | ▼ -98.0% |
| 2011 | 125.26x | CN¥404.62 Million | CN¥3.23 Million | ▲ +1970.9% |
| 2010 | 6.05x | CN¥121.05 Million | CN¥20.01 Million | ▼ -4.6% |
| 2009 | 6.34x | CN¥208.30 Million | CN¥32.86 Million | ▲ +74.3% |
| 2008 | 3.64x | CN¥94.57 Million | CN¥26.00 Million | ▼ -41.9% |
| 2007 | 6.26x | CN¥174.20 Million | CN¥27.82 Million | ▲ +100.8% |
| 2006 | 3.12x | CN¥159.43 Million | CN¥51.13 Million | ▲ +64.5% |
| 2005 | 1.90x | CN¥87.40 Million | CN¥46.10 Million | ▲ +49.6% |
| 2004 | 1.27x | CN¥47.54 Million | CN¥37.52 Million | ▼ -55.9% |
| 2003 | 2.87x | CN¥105.36 Million | CN¥36.69 Million | ▲ +3367.7% |
| 2002 | 0.08x | CN¥2.81 Million | CN¥33.98 Million | ▼ -91.2% |
| 2000 | 0.94x | CN¥7.08 Million | CN¥7.52 Million | ▲ +135.0% |
| 1999 | -2.69x | CN¥-20.52 Million | CN¥7.63 Million | ▼ -330.0% |
| 1998 | 1.17x | CN¥30.10 Million | CN¥25.73 Million | — |